Cargando…

S-1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis

Background: Fluoropyrimidine- and platinum-based doublet regimen is the standard treatment of adjuvant chemotherapy (AC) for gastric cancer (GC). Our study aims to compare S1 with doublet regimens as AC in patients with advanced GC after radical surgery with D2 dissection. Methods: Patients who were...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Meng-Che, Wang, Shih-Ho, Wei, Ching-Ting, Chen, Chung-Yen, Chen, Yen-Yang, Pei, Sung-Nan, Tsai, Yu-Fen, Rau, Kun-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565691/
https://www.ncbi.nlm.nih.gov/pubmed/32842507
http://dx.doi.org/10.3390/cancers12092384
_version_ 1783595987137200128
author Hsieh, Meng-Che
Wang, Shih-Ho
Wei, Ching-Ting
Chen, Chung-Yen
Chen, Yen-Yang
Pei, Sung-Nan
Tsai, Yu-Fen
Rau, Kun-Ming
author_facet Hsieh, Meng-Che
Wang, Shih-Ho
Wei, Ching-Ting
Chen, Chung-Yen
Chen, Yen-Yang
Pei, Sung-Nan
Tsai, Yu-Fen
Rau, Kun-Ming
author_sort Hsieh, Meng-Che
collection PubMed
description Background: Fluoropyrimidine- and platinum-based doublet regimen is the standard treatment of adjuvant chemotherapy (AC) for gastric cancer (GC). Our study aims to compare S1 with doublet regimens as AC in patients with advanced GC after radical surgery with D2 dissection. Methods: Patients who were diagnosed with GC and underwent a curative surgery with D2 dissection followed by AC were enrolled into our study. A propensity score matching analysis was performed to reduce the selection bias. Kaplan–Meier curves were estimated for recurrence-free survival (RFS) and overall survival (OS). Cox regression models were conducted for survival. Results: After propensity sore matching, 64 patients with S1 and 64 patients with doublet regimens were identified. The median RFS (p = 0.355) and OS (p = 0.309) were both insignificant between S1 and ST. Cox regression analysis demonstrated that pathologic stage and lymph node ratio (LNR) were independently correlated with survival. Patients were then stratified into low risk and high risk groups. The median RFS (p < 0.001) and OS (p < 0.001) had significant differences between low risk and high risk. In the high-risk group, doublet regimens were strongly associated with survival (p = 0.020) as compared with S1. While in the low-risk group, doublet regimen and S1 did not have statistically different survival benefits. Conclusions: Our study demonstrated that doublet regimens are superior to S1 in high-risk groups, and that survival outcomes are similar between doublet regimens and S1 in low-risk groups. Our prognostic model might have clinical implications for AC.
format Online
Article
Text
id pubmed-7565691
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75656912020-10-26 S-1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis Hsieh, Meng-Che Wang, Shih-Ho Wei, Ching-Ting Chen, Chung-Yen Chen, Yen-Yang Pei, Sung-Nan Tsai, Yu-Fen Rau, Kun-Ming Cancers (Basel) Article Background: Fluoropyrimidine- and platinum-based doublet regimen is the standard treatment of adjuvant chemotherapy (AC) for gastric cancer (GC). Our study aims to compare S1 with doublet regimens as AC in patients with advanced GC after radical surgery with D2 dissection. Methods: Patients who were diagnosed with GC and underwent a curative surgery with D2 dissection followed by AC were enrolled into our study. A propensity score matching analysis was performed to reduce the selection bias. Kaplan–Meier curves were estimated for recurrence-free survival (RFS) and overall survival (OS). Cox regression models were conducted for survival. Results: After propensity sore matching, 64 patients with S1 and 64 patients with doublet regimens were identified. The median RFS (p = 0.355) and OS (p = 0.309) were both insignificant between S1 and ST. Cox regression analysis demonstrated that pathologic stage and lymph node ratio (LNR) were independently correlated with survival. Patients were then stratified into low risk and high risk groups. The median RFS (p < 0.001) and OS (p < 0.001) had significant differences between low risk and high risk. In the high-risk group, doublet regimens were strongly associated with survival (p = 0.020) as compared with S1. While in the low-risk group, doublet regimen and S1 did not have statistically different survival benefits. Conclusions: Our study demonstrated that doublet regimens are superior to S1 in high-risk groups, and that survival outcomes are similar between doublet regimens and S1 in low-risk groups. Our prognostic model might have clinical implications for AC. MDPI 2020-08-23 /pmc/articles/PMC7565691/ /pubmed/32842507 http://dx.doi.org/10.3390/cancers12092384 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hsieh, Meng-Che
Wang, Shih-Ho
Wei, Ching-Ting
Chen, Chung-Yen
Chen, Yen-Yang
Pei, Sung-Nan
Tsai, Yu-Fen
Rau, Kun-Ming
S-1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis
title S-1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis
title_full S-1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis
title_fullStr S-1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis
title_full_unstemmed S-1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis
title_short S-1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis
title_sort s-1 versus doublet regimens as adjuvant chemotherapy in patients with advanced gastric cancer after radical surgery with d2 dissection—a propensity score matching analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565691/
https://www.ncbi.nlm.nih.gov/pubmed/32842507
http://dx.doi.org/10.3390/cancers12092384
work_keys_str_mv AT hsiehmengche s1versusdoubletregimensasadjuvantchemotherapyinpatientswithadvancedgastriccancerafterradicalsurgerywithd2dissectionapropensityscorematchinganalysis
AT wangshihho s1versusdoubletregimensasadjuvantchemotherapyinpatientswithadvancedgastriccancerafterradicalsurgerywithd2dissectionapropensityscorematchinganalysis
AT weichingting s1versusdoubletregimensasadjuvantchemotherapyinpatientswithadvancedgastriccancerafterradicalsurgerywithd2dissectionapropensityscorematchinganalysis
AT chenchungyen s1versusdoubletregimensasadjuvantchemotherapyinpatientswithadvancedgastriccancerafterradicalsurgerywithd2dissectionapropensityscorematchinganalysis
AT chenyenyang s1versusdoubletregimensasadjuvantchemotherapyinpatientswithadvancedgastriccancerafterradicalsurgerywithd2dissectionapropensityscorematchinganalysis
AT peisungnan s1versusdoubletregimensasadjuvantchemotherapyinpatientswithadvancedgastriccancerafterradicalsurgerywithd2dissectionapropensityscorematchinganalysis
AT tsaiyufen s1versusdoubletregimensasadjuvantchemotherapyinpatientswithadvancedgastriccancerafterradicalsurgerywithd2dissectionapropensityscorematchinganalysis
AT raukunming s1versusdoubletregimensasadjuvantchemotherapyinpatientswithadvancedgastriccancerafterradicalsurgerywithd2dissectionapropensityscorematchinganalysis